Ashwagandha boosts memory and mood in clinical trial

FHS
June 11, 2024
3:01 am

A clinical trial found that acute and 30-day Ashwagandha supplementation improves cognitive function and mood markers, showing significant benefits in memory, attention, and well-being without adverse effects.

Acorda files for bankruptcy, agrees to sell MS drug and other assets to Merz for $185M

Acorda Therapeutics’ stock tanked Tuesday after announcing Chapter 11 bankruptcy and the sale of its assets to Merz Therapeutics for $185 million. The once high-flying

April 3, 2024

Prolonged inactivity affects cholesteryl esters differently depending on age

A new study examining cholesteryl esters suggests that periods of prolonged inactivity may affect people differently depending on their age.

March 25, 2024

‘Humbling, Exhausting, Exhilarating’: The Life of AMA President Jesse Ehrenfeld

WASHINGTON — “Humbling, exhausting, and exhilarating.” That’s how Jesse Ehrenfeld, MD, MPH, president of the American Medical Association (AMA), described his experience so far, 8

February 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.